Patent Assignment
Reel/Frame 050267/0097
Assignment of Assignor's Interest
Recorded: 2019-09-04
Pages: 3
Assignor
RASCON, LUCAS
Executed: 2019-08-27
Assignee
INHIBRX, INC.
11025 N. TORREY PINES ROAD, SUITE 200, LA JOLLA, CALIFORNIA, 92037
Covered Properties
(2)
Multivalent and Multispecific 41BB-Binding Fusion Proteins
Patent:
10,501,551 →
Application:
15/404,016 →
Publication:
US 2017/0198050
PCT:
PCT/US2017/013040 ↗
Multivalent and Multispecific CD137-Binding Fusion Proteins
Application:
62/277,028 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 14, 2016
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; HATA, CHELSIE; JONES, KYLE S.
To: INHIBRX LP
Reel/Frame 038281/0972 →
Assignment of Assignor's Interest
Jun 26, 2017
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; HATA, CHELSIE; JONES, KYLE S.
To: INHIBRX LP
Reel/Frame 042816/0394 →
Merger and Change of Name
May 22, 2018
From: INHIBRX LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 046215/0084 →
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0831 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067679/0338 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →